Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment

Hujun Li; Lingling Yin; Ying Wang; Xiangmin Wang; Ming Shi; Jiang Cao; Zhiling Yan; Wei Sang; Hai Cheng; Feng Zhu; Haiying Sun; Depeng Li; Guangjun Jing; Junnian Zheng; Zhenyu Li; Kailin Xu

doi:10.1038/s41409-020-0930-5

Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment

Bone Marrow Transplant. 2020 Nov;55(11):2215-2218. doi: 10.1038/s41409-020-0930-5. Epub 2020 May 9.

Authors

Hujun Li^#^{1

2

3}, Lingling Yin^#^{1

2

3}, Ying Wang^#^{1

2

3}, Xiangmin Wang^{1

2

3}, Ming Shi^{4

5}, Jiang Cao^{1

2

3}, Zhiling Yan^{1

2

3}, Wei Sang^{1

2

3}, Hai Cheng^{1

2

3}, Feng Zhu^{1

2

3}, Haiying Sun^{1

2

3}, Depeng Li^{1

2

3}, Guangjun Jing⁶, Junnian Zheng^{7

8}, Zhenyu Li^{9

10

11}, Kailin Xu^{12

13

14}

Affiliations

¹ Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
² Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
³ Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China.
⁴ Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
⁵ Cacer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
⁶ iCARTAB Biomedical Co Ltd, Suzhou, Jiangsu, China.
⁷ Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China. [email protected].
⁸ Cacer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China. [email protected].
⁹ Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China. [email protected].
¹⁰ Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China. [email protected].
¹¹ Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China. [email protected].
¹² Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China. [email protected].
¹³ Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China. [email protected].
¹⁴ Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China. [email protected].

^# Contributed equally.

PMID: 32388534
DOI: 10.1038/s41409-020-0930-5

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Cell- and Tissue-Based Therapy
Humans
Immunotherapy, Adoptive
Multiple Myeloma* / therapy
Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen*
T-Lymphocytes

Substances

Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen

Publication types

MeSH terms

Substances

Grants and funding